BACKGROUND AND PURPOSE: Individualizing mean arterial blood pressure targets to a patient's cerebral blood flow autoregulatory range might prevent brain ischemia for patients undergoing cardiopulmonary bypass (CPB). This study compares the accuracy of real-time cerebral blood flow autoregulation monitoring using near-infrared spectroscopy with that of transcranial Doppler. METHODS: Sixty adult patients undergoing CPB had transcranial Doppler monitoring of middle cerebral artery blood flow velocity and near-infrared spectroscopy monitoring. The mean velocity index (Mx) was calculated as a moving, linear correlation coefficient between slow waves of middle cerebral artery blood flow velocity and mean arterial blood pressure. The cerebral oximetry index was calculated as a similar coefficient between slow waves of cerebral oximetry and mean arterial blood pressure. When cerebral blood flow is autoregulated, Mx and cerebral oximetry index vary around zero. Loss of autoregulation results in progressively more positive Mx and cerebral oximetry index. RESULTS: Mx and cerebral oximetry index showed significant correlation (r=0.55, P<0.0001) and good agreement (bias, 0.08+/-0.18, 95% limits of agreement: -0.27 to 0.43) during CPB. Autoregulation was disturbed in this cohort during CPB (average Mx 0.38, 95% CI 0.34 to 0.43). The lower cerebral blood flow autoregulatory threshold (defined as incremental increase in Mx >0.45) during CPB ranged from 45 to 80 mm Hg. CONCLUSIONS: Cerebral blood flow autoregulation can be monitored continuously with near-infrared spectroscopy in adult patients undergoing CPB. Real-time autoregulation monitoring may have a role in preventing injurious hypotension during CPB. Clinical Trials Registration- at www.clinicaltrials.gov (NCT00769691).
BACKGROUND AND PURPOSE: Individualizing mean arterial blood pressure targets to a patient's cerebral blood flow autoregulatory range might prevent brain ischemia for patients undergoing cardiopulmonary bypass (CPB). This study compares the accuracy of real-time cerebral blood flow autoregulation monitoring using near-infrared spectroscopy with that of transcranial Doppler. METHODS: Sixty adult patients undergoing CPB had transcranial Doppler monitoring of middle cerebral artery blood flow velocity and near-infrared spectroscopy monitoring. The mean velocity index (Mx) was calculated as a moving, linear correlation coefficient between slow waves of middle cerebral artery blood flow velocity and mean arterial blood pressure. The cerebral oximetry index was calculated as a similar coefficient between slow waves of cerebral oximetry and mean arterial blood pressure. When cerebral blood flow is autoregulated, Mx and cerebral oximetry index vary around zero. Loss of autoregulation results in progressively more positive Mx and cerebral oximetry index. RESULTS: Mx and cerebral oximetry index showed significant correlation (r=0.55, P<0.0001) and good agreement (bias, 0.08+/-0.18, 95% limits of agreement: -0.27 to 0.43) during CPB. Autoregulation was disturbed in this cohort during CPB (average Mx 0.38, 95% CI 0.34 to 0.43). The lower cerebral blood flow autoregulatory threshold (defined as incremental increase in Mx >0.45) during CPB ranged from 45 to 80 mm Hg. CONCLUSIONS: Cerebral blood flow autoregulation can be monitored continuously with near-infrared spectroscopy in adult patients undergoing CPB. Real-time autoregulation monitoring may have a role in preventing injurious hypotension during CPB. Clinical Trials Registration- at www.clinicaltrials.gov (NCT00769691).
Authors: Susan L Bratton; Randall M Chestnut; Jamshid Ghajar; Flora F McConnell Hammond; Odette A Harris; Roger Hartl; Geoffrey T Manley; Andrew Nemecek; David W Newell; Guy Rosenthal; Joost Schouten; Lori Shutter; Shelly D Timmons; Jamie S Ullman; Walter Videtta; Jack E Wilberger; David W Wright Journal: J Neurotrauma Date: 2007 Impact factor: 5.269
Authors: R M Schell; F H Kern; W J Greeley; S R Schulman; P E Frasco; N D Croughwell; M Newman; J G Reves Journal: Anesth Analg Date: 1993-04 Impact factor: 5.108
Authors: Robert Moraca; Eugene Lin; James H Holmes; David Fordyce; William Campbell; Mary Ditkoff; Mark Hill; Steven Guyton; Daniel Paull; R Alan Hall Journal: J Thorac Cardiovasc Surg Date: 2006-01-31 Impact factor: 5.209
Authors: Pawan S Minhas; Piotr Smielewski; Peter J Kirkpatrick; John D Pickard; Marek Czosnyka Journal: Neurosurgery Date: 2004-07 Impact factor: 4.654
Authors: Luzius A Steiner; Marek Czosnyka; Stefan K Piechnik; Piotr Smielewski; Doris Chatfield; David K Menon; John D Pickard Journal: Crit Care Med Date: 2002-04 Impact factor: 7.598
Authors: Ken M Brady; Jennifer K Lee; Kathleen K Kibler; Piotr Smielewski; Marek Czosnyka; R Blaine Easley; Raymond C Koehler; Donald H Shaffner Journal: Stroke Date: 2007-08-30 Impact factor: 7.914
Authors: Yueying Zheng; April J Villamayor; William Merritt; Aliaksei Pustavoitau; Asad Latif; Ramola Bhambhani; Steve Frank; Ahmet Gurakar; Andrew Singer; Andrew Cameron; Robert D Stevens; Charles W Hogue Journal: Neurocrit Care Date: 2012-08 Impact factor: 3.210
Authors: Jennifer K Lee; Zeng-Jin Yang; Bing Wang; Abby C Larson; Jessica L Jamrogowicz; Ewa Kulikowicz; Kathleen K Kibler; Jennifer O Mytar; Erin L Carter; Hillary T Burman; Ken M Brady; Peter Smielewski; Marek Czosnyka; Raymond C Koehler; Donald H Shaffner Journal: Anesth Analg Date: 2012-02-07 Impact factor: 5.108
Authors: Krishma Adatia; Romergryko G Geocadin; Ryan Healy; Wendy Ziai; Luciano Ponce-Mejia; Mirinda Anderson-White; Dhaval Shah; Batya R Radzik; Caitlin Palmisano; Charles W Hogue; Charles Brown; Lucia Rivera-Lara Journal: Crit Care Med Date: 2018-08 Impact factor: 7.598